MHRA Class 2 Medicines Recall: Bricanyl Injection, 0.5 mg/ml solution for injection or infusion

MHRA Class 2 Medicines Recall: Bricanyl Injection, 0.5 mg/ml solution for injection or infusion

May 17, 2021

MHRA Class 2 Medicines Recall: AstraZeneca UK Limited, Bricanyl Injection, 0.5 mg/ml solution for injection or infusion (PL 17901/0112), EL (21)A/12

Drug alert number: EL (21)A/12

MDR Number: MDR 015-05/21

Date issued: 17th May 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 medicines recall for: Bricanyl Injection, 0.5 mg/ml solution for injection or infusion (PL 17901/0112)

Brief description of the problem

AstraZeneca UK Limited is recalling the batch listed below of Bricanyl 0.5mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing.

Batch Number Expiry Date Pack Size First Distributed
F1029-1 August 2021 5 x 1 mL ampoules November 2019

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug safety notice can be viewed here.

Contact details for further information

For more information or medical information queries please contact Tel: +44 (0) 0800 783 0033 Email: medical.informationuk@astrazeneca.com

For supply queries, please contact Tel: +44 (0) 800 783 0033 (option 1) Email: supply.chain@astrazeneca.com



Posted in:


More Latest News >